Coloplast A/S (OTCMKTS:CLPBY) Posts Earnings Results

Coloplast A/S (OTCMKTS:CLPBYGet Free Report) announced its quarterly earnings data on Tuesday. The company reported $0.08 earnings per share (EPS) for the quarter, reports. The company had revenue of $1.02 billion during the quarter. Coloplast A/S had a net margin of 18.89% and a return on equity of 31.39%. Coloplast A/S updated its FY 2025 guidance to EPS.

Coloplast A/S Stock Up 0.3 %

CLPBY stock traded up $0.04 during trading on Friday, reaching $13.28. 85,038 shares of the stock traded hands, compared to its average volume of 130,593. The business’s 50 day moving average price is $13.22 and its 200-day moving average price is $12.84. The company has a debt-to-equity ratio of 1.00, a current ratio of 0.85 and a quick ratio of 0.56. Coloplast A/S has a 52-week low of $9.90 and a 52-week high of $14.34.

About Coloplast A/S

(Get Free Report)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.

Featured Stories

Earnings History for Coloplast A/S (OTCMKTS:CLPBY)

Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.